Chronic kidney disease trials in France

In France 83 Also abroad 798

83 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Where
Paris
Age
1 year to 17 years
People
10 worldwide
Run by
Hansa Biopharma AB
See details and how to joinNCT05753930 · EU 2022-500230-28-00
Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Amiens Cedex 1, Bois-Guillaume, Bordeaux, Boulogne-Billancourt, Brest, Clermont Ferrand Cedex 1, Creteil, La Roche Sur Yon Cedex 9, Le Mans Cedex 9, Limoges, Lyon Cedex 03, Marseille, Nancy Cedex, Nantes, Nice, Nimes Cedex 9, Paris, Paris Cedex 18, Pierre-Bénite, Poitiers, Quimper Cedex, Reims, Saint-Priest-en-Jarez, Sarcelles, Strasbourg Cedex, Tours
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
No phaseTaking people
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Where
Paris
Age
18 years and over
People
165
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT07604922
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Bois-Guillaume, Clermont-Ferrand, La Tronche, Le Coudray, Lyon, Mulhouse, Nantes, Nice, Paris, Saint-Herblain, Toulouse Cedex 9, Tours Cedex 9, Vandoeuvre Les Nancy
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
No phaseEnrolling by invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Where
Toulouse
Age
0 Minutes to 2 weeks
People
8,000 worldwide
Run by
Indiana University
See details and how to joinNCT06823115
No phaseNot yet taking people in France
Microbiota Changes Related to Outcomes in Kidney Transplantation
Where
Lyon
Age
18 years and over
People
30
Run by
Hospices Civils de Lyon
See details and how to joinNCT07893691
No phaseTaking people
Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France
Where
Alès, Nîmes
People
3,375
Run by
Centre Hospitalier Universitaire de Nīmes
See details and how to joinNCT02938611
No phaseTaking people
Hyperlipoproteinemia A as a Marker of Cardiovascular Risk in Patients With Stage 4 Chronic Kidney Disease
Where
Nîmes
Age
18 years to 80 years
People
300
Run by
Centre Hospitalier Universitaire de Nīmes
See details and how to joinNCT07141628
No phaseTaking people
Evaluation of Depression Screening Methods Administered by Registered Nurses in Chronic Hemodialysis Patients
Where
Annecy, Chambéry
Age
18 years and over
People
450
Run by
Centre Hospitalier Annecy Genevois
See details and how to joinNCT07651436
No phaseNot yet taking people in France
Evaluation of the Effect of Light Therapy on the Evolution of Self-reported Depressive Disorders in Chronic Hemodialysis Patients
Where
Annecy
Age
18 years and over
People
340
Run by
Centre Hospitalier Annecy Genevois
See details and how to joinNCT07729358
No phaseNot yet taking people in France
A Minute for my Kidneys
Where
Lille
Age
18 years to 80 years
People
312
Run by
GCS Ramsay Santé pour l'Enseignement et la Recherche
See details and how to joinNCT07869849
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Marseille, Montpellier Cedex 5, Paris
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 1/2Taking people
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Where
Villejuif
Age
18 years and over
People
75 worldwide
Run by
Oncorena AB
See details and how to joinNCT05287945
Phase 3Taking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Bordeaux, Bron, Montpellier, Paris, Strasbourg Cedex 2, Toulouse Cedex 9
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 3Taking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
Boulogne-sur-Mer, Caen, Cherbourg, Colmar, La Roche-sur-Yon, Le Mans, Marseille, Nîmes, Orléans, Rouen, Saint-Priez En Jarez, Toulouse, Tours
Age
18 years to 99 years
People
2,800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Amiens, Aura, Brest, Caen, Compiègne, Grabels, Lille, Limoges, Marseille, Montpellier, Nice, Nîmes, Paris, Reims, Saint-Ouen, Strasbourg, Toulouse
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
No phaseTaking people
Prospective Analysis of Self Medication With Phytotherapy in Nephropatic Patients.
Where
Saint-Benoît, Saint-Denis, Saint-Paul, Saint-Pierre
Age
18 years and over
People
400
Run by
Centre Hospitalier Universitaire de la Réunion
See details and how to joinNCT07444515
Phase 4Taking people
Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2
Where
Nice
Age
18 years to 80 years
People
34
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07074418
No phaseNot yet taking people in France
CXCR2 Leucocyte Expression Level as a Predictive Factor of Coronary Artery Calcification Progression in Advanced Chronic Kidney Disease Patients
Where
Amiens
Age
18 years and over
People
100
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT07811505
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Bordeaux, Clermont-Ferrand, Corbeil-Essonnes, Epagny Metz-tessy, Grenoble Cedex 9, La Rochelle, Laval, Le Kremlin-Bicetre, Le Puy-En-Velay, Lyon, Montpellier, Nantes, Orleans Cedex 2, Pierre-Bénite, Pontoise, Saint-Priest-en-Jarez, Toulouse Cedex 9, Valenciennes
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
No phaseTaking people
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
Where
Paris
Age
18 years and over
People
3,600 worldwide
Run by
The University of Queensland
See details and how to joinNCT03573089
Phase 3Taking people
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Where
Bron, Paris
Age
2 years to 17 years
People
24 worldwide
Run by
Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00
No phaseNot yet taking people in France
Do Endocrine Disruptors Accumulate in Children Undergoing Paediatric Dialysis?
Where
Bron
Age
2 years to 17 years
People
15
Run by
Hospices Civils de Lyon
See details and how to joinNCT07763483
No phaseTaking people
Study of the Quality of Life in School Aged-children With Posterior Urethral Valves
Where
Bron
Age
6 years to 17 years
People
300
Run by
Hospices Civils de Lyon
See details and how to joinNCT06439862
No phaseTaking people
Impact of Bevel Orientation on Arteriovenous Fistula Puncture in Hemodialysis
Where
Le Puy-en-Velay, Lyon, Moulins, Poissy
Age
18 years to 85 years
People
240
Run by
Centre Hospitalier Emile Roux
See details and how to joinNCT06708338